Synthesis of 5-isoxazol-5-yl-2′-deoxyuridines exhibiting antiviral activity against HSV and several RNA viruses

[1]  E. De Clercq,et al.  5-alkynyl analogs of arabinouridine and 2'-deoxyuridine: cytostatic activity against herpes simplex virus and varicella-zoster thymidine kinase gene-transfected cells. , 2007, Journal of medicinal chemistry.

[2]  Francesco De Sarlo,et al.  1,4-Diazabicyclo[2.2.2]octane (DABCO) as an Efficient Reagent for the Synthesis of Isoxazole Derivatives from Primary Nitro Compounds and Dipolarophiles: The Role of the Base , 2006 .

[3]  E. Clercq.  New approaches toward anti-HIV chemotherapy. , 2005 .

[4]  Fahmi Himo,et al.  Copper(I)-catalyzed synthesis of azoles. DFT study predicts unprecedented reactivity and intermediates. , 2005, Journal of the American Chemical Society.

[5]  B. Kim,et al.  Novel low-molecular-weight hydrogelators based on 2'-deoxyuridine. , 2003, Chemical communications.

[6]  B. Kim,et al.  Heterocyclic nucleoside analogues: design and synthesis of antiviral, modified nucleosides containing isoxazole heterocycles. , 2002, Bioorganic & medicinal chemistry letters.

[7]  B. Kim,et al.  TT DINUCLEOTIDES CONTAINING AN ISOXAZOLINE MOIETY: SYNTHESIS AND BINDING AFFINITY STUDY , 2001, Nucleosides, nucleotides & nucleic acids.

[8]  S. J. Kim,et al.  Design and synthesis of isoxazole and isoxazoline linkage for replacement of nucleotide phosphodiester. , 1998, Bioorganic & medicinal chemistry letters.

[9]  P. Herdewijn,et al.  Relationship between structural properties and affinity for herpes simplex virus type 1 thymidine kinase of bromine substituted 5-heteroaromatic 2'-deoxyuridines. , 1996, Antiviral research.

[10]  D. Bloom,et al.  Molecular analysis of herpes simplex virus type 1 during epinephrine-induced reactivation of latently infected rabbits in vivo , 1994, Journal of virology.

[11]  E. De Clercq,et al.  Synthesis and antiviral activity of 5-thien-2-yl-2'-deoxyuridine analogues. , 1993, Journal of medicinal chemistry.

[12]  E. De Clercq,et al.  5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication. , 1991, Journal of medicinal chemistry.

[13]  S. Manfredini,et al.  Nucleic acid related compounds. 65. New syntheses of 1-(beta-D-arabinofuranosyl)-5(E)-(2-iodovinyl)uracil (IVAraU) from vinylsilane precursors. Radioiodine uptake as a marker for thymidine kinase positive herpes viral infections. , 1991, Journal of medicinal chemistry.

[14]  E. De Clercq,et al.  Synthesis of (E)-5-(3,3,3-trifluoro-1-propenyl)-2'-deoxyuridine and related analogues: potent and unusually selective antiviral activity of (E)-5-(3,3,3-trifluoro-1-propenyl)-2'-deoxyuridine against herpes simplex virus type 1. , 1984, Journal of medicinal chemistry.

[15]  Y. Cheng,et al.  Anti-herpes simplex virus and anti-human cell growth activity of E-5-propenyl-2'-deoxyuridine and the concept of selective protection in antivirus chemotherapy , 1980, Antimicrobial Agents and Chemotherapy.

[16]  R. T. Walker,et al.  Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. , 1980, The Journal of infectious diseases.

[17]  P. Torrence,et al.  5-O-Alkylated derivatives of 5-hydroxy-2'-deoxyuridine as potential antiviral agents. Anti-herpes activity of 5-propynyloxy-2'-deoxyuridine. , 1978, Journal of medicinal chemistry.